COMPARISON BETWEEN INTRAVENOUS AND SUBCUTANEOUS ERYTHROPOIETIN IN DIALYSIS PATIENTS

被引：0
|
作者：
JENSEN, JD [1 ]
MADSEN, JK [1 ]
JENSEN, LW [1 ]
机构：
[1] AARHUS UNIV HOSP,SKEJBY HOSP,DEPT NEPHROL & MED C,DK-8000 AARHUS,DENMARK
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1994年 / 5卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [31] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
    BARNAS, U
    WATZINGER, U
    PEER, G
    MAYER, G
    GRAF, H
    [J]. NEFROLOGIA, 1990, 10 : 116 - 120
  • [32] EFFICACY OF SUBCUTANEOUS VS INTRAVENOUS MAINTENANCE THERAPY WITH ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    FREUDIGER, H
    GLUCK, Z
    [J]. KIDNEY INTERNATIONAL, 1991, 39 (06) : 1330 - 1330
  • [33] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
    EIDEMAK, I
    FRIEDBERG, MO
    LADEFOGED, SD
    LOKKEGAARD, H
    PEDERSEN, E
    SKIELBOE, M
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
  • [34] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    [J]. NEPHRON, 1993, 63 (01) : 113 - 114
  • [35] INTRAVENOUS (IV) VS SUBCUTANEOUS (SC) ADMINISTRATION OF ERYTHROPOIETIN (EPO) IN HEMODIALYSIS (HD) PATIENTS
    VIDAU, P
    PERAL, V
    TOME, R
    RODRIGUEZ, C
    HERRERA, J
    [J]. KIDNEY INTERNATIONAL, 1994, 46 (02) : 571 - 571
  • [36] Association between erythropoietin responsiveness and body composition in dialysis patients
    Kotanko, Peter
    Thijssen, Stephan
    Levin, Nathan W.
    [J]. BLOOD PURIFICATION, 2008, 26 (01) : 82 - 89
  • [37] Comparison of intraperitoneal and subcutaneous epoetin alfa in peritoneal dialysis patients
    Johnson, CA
    Wakeen, M
    Taylor, CA
    Zimmerman, SW
    Burkart, J
    Bhattacharya, A
    Kosorok, MR
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (06): : 578 - 582
  • [38] Dialysis: Subcutaneous erythropoietin administration increases the risk of access failure
    Lucchese B.
    [J]. Nature Reviews Nephrology, 2009, 5 (8) : 431 - 431
  • [39] RESISTANCE TO ERYTHROPOIETIN IN DIALYSIS PATIENTS
    TZAMALOUKAS, AH
    [J]. DIALYSIS & TRANSPLANTATION, 1994, 23 (01) : 20 - 20
  • [40] ERYTHROPOIETIN REQUIREMENT OF DIALYSIS PATIENTS
    Ozturk, Y.
    Corakci, B. Delikanli
    Bilici, M.
    Ertop, S.
    Borazan, A.
    [J]. LEUKEMIA RESEARCH, 2017, 61 : S21 - S21
12345